Triastek, Inc.

Triastek, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Triastek is a global leader in 3D printing pharmaceuticals, pioneering the next generation of digital pharmaceutical processes. Founded in July 2015, Triastek is dedicated to the mission of "revolutionizing the pharmaceutical industry, unlocking the next generation of medicine and benefitting patients worldwide." We have created the Melt Extrusion Deposition (MED®) 3D printing pharmaceutical process, transforming the delivery, development, and production of medication through digital product development and continuous manufacturing. Leveraging our proprietary 3D printing pharmaceutical technology, we design and develop transformative medications for patients. Through collaboration with global pharmaceutical companies, we tackle challenging formulation issues, accelerating the development of new drug products and improving the quality of pharmaceuticals. Our vision is to become the world's most influential intelligent pharmaceutical enterprise.

Company Details

Employees
36
Founded
-
Address
No. 24 Building, Max Science Business Park, 99 Lize Road, Nanjing,jiangsu 211111,china
Phone
86-25-52713121
Email
in****@****tek.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Nanjing, Jiangsu
Looking for a particular Triastek, Inc. employee's phone or email?

Triastek, Inc. Questions

News

Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance - Business Wire

Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance Business Wire

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results - Yahoo Finance

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results Yahoo Finance

Triastek Advances 3D Printed D23 Budesonide Tablets for IgAN Treatment - 3D Printing Industry

Triastek Advances 3D Printed D23 Budesonide Tablets for IgAN Treatment 3D Printing Industry

Triastek and BioNTech to develop 3D-printed RNA therapeutics - Pharmaceutical Technology

Triastek and BioNTech to develop 3D-printed RNA therapeutics Pharmaceutical Technology

Triastek to open 3D printed pharmaceutical production facility - VoxelMatters

Triastek to open 3D printed pharmaceutical production facility VoxelMatters

Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application - GlobeNewswire

Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application GlobeNewswire

Biontech, Triastek ink $1.2B deal to 3D print oral RNA therapies - BioWorld MedTech

Biontech, Triastek ink $1.2B deal to 3D print oral RNA therapies BioWorld MedTech

Triastek Receives FDA IND Clearance for 3D Printed Product of Blockbuster Molecule - PR Newswire

Triastek Receives FDA IND Clearance for 3D Printed Product of Blockbuster Molecule PR Newswire

Lilly taps Triastek to use 3D printing for gut-targeted drug delivery - Fierce Pharma

Lilly taps Triastek to use 3D printing for gut-targeted drug delivery Fierce Pharma

Triastek Completes USD 20.4 Million Pre-C Funding Round to - GlobeNewswire

Triastek Completes USD 20.4 Million Pre-C Funding Round to GlobeNewswire

Triastek advances 3D printed drug D23 for IgAN treatment - VoxelMatters

Triastek advances 3D printed drug D23 for IgAN treatment VoxelMatters

FDA Grants IND Approval to Triastek’s 3D Printed Oral Anticoagulant T20G - 3D Printing Industry

FDA Grants IND Approval to Triastek’s 3D Printed Oral Anticoagulant T20G 3D Printing Industry

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics - Business Wire

Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics Business Wire

Triastek Honored with 2023 Healthcare Application Award at - GlobeNewswire

Triastek Honored with 2023 Healthcare Application Award at GlobeNewswire

Triastek’s T22 3D printed gastric retention drug receives FDA clearance - 3D Printing Industry

Triastek’s T22 3D printed gastric retention drug receives FDA clearance 3D Printing Industry

Triastek receives FDA IND clearance for 3D printed drug to treat rheumatoid arthritis - 3D Printing Industry

Triastek receives FDA IND clearance for 3D printed drug to treat rheumatoid arthritis 3D Printing Industry

Triastek’s 3D printed drug T21 shows promise in treating ulcerative colitis - 3D Printing Industry

Triastek’s 3D printed drug T21 shows promise in treating ulcerative colitis 3D Printing Industry

Triastek and Eli Lilly partner to 3D print gastrointestinal drugs - 3D Printing Industry

Triastek and Eli Lilly partner to 3D print gastrointestinal drugs 3D Printing Industry

Top Triastek, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant